Fei Su
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- Melanoma and MAPK Pathways
- Circular RNAs in diseases
- Ginseng Biological Effects and Applications
- RNA modifications and cancer
Papers in
-
- RNA modifications and cancer 14
- RNA Research and Splicing 10
- Bioinformatics and Genomic Networks 10
- Melanoma and MAPK Pathways 9
- Circular RNAs in diseases 8
- Genomics and Phylogenetic Studies 6
-
- Cancer-related molecular mechanisms research 18
- MicroRNA in disease regulation 13
- Co-authors
- Robert J. Schneider (1 shared paper)Songhua Hu (6 shared papers)Ping Xu (9 shared papers)Arnold J. Levine (2 shared papers)Kenneth Kolinsky (5 shared papers)Kathryn Packman (6 shared papers)Mary Ellen Simcox (2 shared papers)Gideon Bollag (5 shared papers)
- Journals
- Scientific Reports (6 papers)Cancer Research (5 papers)Journal of Bacteriology (4 papers)Oncotarget (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Fei Su
119 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 138
- Cancer Research 560
- Molecular Biology 1.7k
- Oncology 516
- Pharmacology 108
- Immunology 214
Countries citing papers authored by Fei Su
This map shows the geographic impact of Fei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Su more than expected).
Fields of papers citing papers by Fei Su
This network shows the impact of papers produced by Fei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Su. The network helps show where Fei Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 128 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 308 | |
| 2 | 1996 | 200 | |
| 3 | 2011 | 171 | |
| 4 | 2013 | 160 | |
| 5 | 2002 | 131 | |
| 6 | 2018 | 120 | |
| 7 | 2012 | 95 | |
| 8 | 2003 | 92 | |
| 9 | 2012 | 54 | |
| 10 | 2017 | 53 | |
| 11 | 2012 | 53 | |
| 12 | 2014 | 50 | |
| 13 | 2013 | 50 | |
| 14 | 2017 | 50 | |
| 15 | 2015 | 42 | |
| 16 | 2012 | 37 | |
| 17 | 2021 | 36 | |
| 18 | 2021 | 33 | |
| 19 | 2019 | 33 | |
| 20 | 2015 | 31 |
About Fei Su
Fei Su is a scholar working on Molecular Biology, Cancer Research, Oncology, Ecology and Pulmonary and Respiratory Medicine, having authored 128 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (18 papers), RNA modifications and cancer (14 papers), MicroRNA in disease regulation (13 papers), RNA Research and Splicing (10 papers), Bioinformatics and Genomic Networks (10 papers), Melanoma and MAPK Pathways (9 papers), Circular RNAs in diseases (8 papers) and Genomics and Phylogenetic Studies (6 papers). The work is most often cited by research in Cancer Research (560 citations), Molecular Biology (1.7k citations), Oncology (516 citations), Pharmacology (108 citations) and Immunology (214 citations). Fei Su has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Robert J. Schneider, Songhua Hu, Ping Xu, Arnold J. Levine, Kenneth Kolinsky, Kathryn Packman, Mary Ellen Simcox, Gideon Bollag, David Heimbrook and Hong Yang. Their work appears in journals such as Scientific Reports, Cancer Research, Journal of Bacteriology, Oncotarget and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.